Prediabetes and associated disorders (Q38257985)

1 September 2017

1 reference

title

Prediabetes and associated disorders (English)

1 reference

1 September 2017

Michael Bergman

3

0 references

author name string

Martin Buysschaert

1

1 reference

1 September 2017

José Luís Medina

2

1 reference

1 September 2017

Avni Shah

4

1 reference

1 September 2017

Jaqueline Lonier

5

1 reference

1 September 2017

language of work or name

1 reference

8 October 2014

1 reference

1 September 2017

1 reference

1 September 2017

volume

48

1 reference

1 September 2017

issue

2

1 reference

1 September 2017

page(s)

371-393

1 reference

Definition of Prediabetes

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Prediabetes: a high-risk state for diabetes development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Definition of intervention points in prediabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Diabetes, prediabetes and cardiovascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Prevalence of prediabetes and newly diagnosed diabetes in patients with a transient ischemic attack or stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Blood glucose concentrations < or = 125 mg/dl and coronary heart disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Cardiovascular risk profile in subjects with prediabetes and new-onset type 2 diabetes identified by HbA(1c) according to American Diabetes Association criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Categories of glucose tolerance and continuous glycemic measures and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Fasting glucose levels within the high normal range predict cardiovascular outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

PubMed Central: creating an Aladdin's cave of ideas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Two-hour post-load plasma glucose levels are associated with carotid intima-media thickness in subjects with normal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Diabetes mellitus, fasting glucose, and risk of cause-specific death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Impaired fasting plasma glucose and type 2 diabetes are related to the risk of out-of-hospital sudden cardiac death and all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabete

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Cardiovascular risk stratification and management in pre-diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Fasting and post-challenge glucose as quantitative cardiovascular risk factors: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Mechanisms of vascular complications in prediabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Standards of medical care in diabetes--2014

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Periodontitis and diabetes: a two-way relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Effect of glycemic control on self-perceived oral health, periodontal parameters, and alveolar bone loss among patients with prediabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Periodontal infection, impaired fasting glucose and impaired glucose tolerance: results from the Continuous National Health and Nutrition Examination Survey 2009-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Pre-diabetes and diabetes: Medical risk factors and periodontal conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Diabetes and cognitive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Diabetes, dysglycemia and cognitive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Neurocognitive functioning in children and adolescents at the time of type 1 diabetes diagnosis: associations with glycemic control 1 year after diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Cognitive decline in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

(Pre)diabetes, brain aging, and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Intensive glucose lowering and cognition in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Higher glucose levels associated with lower memory and reduced hippocampal microstructure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Relationship between markers of insulin resistance, markers of adiposity, HbA1c, and cognitive functions in a middle-aged population-based sample: the MONA LISA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Glucose tolerance status and risk of dementia in the community: the Hisayama study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Glucose levels and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Physical function limitations among middle-aged and older adults with prediabetes: one exercise prescription may not fit all.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Risk of dementia in diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Effect of diabetes on brain structure: the action to control cardiovascular risk in diabetes MR imaging baseline data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Insulin action in brain regulates systemic metabolism and brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Trajectories of the Framingham general cardiovascular risk profile in midlife and poor motor function later in life: the Whitehall II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

A new look at screening and diagnosing diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Retinal vascular changes in pre-diabetes and prehypertension: new findings and their research and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Neuropathy in prediabetes: does the clock start ticking early?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

The spectrum of neuropathy in diabetes and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: the KORA F4 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Screening for kidney disease in adults with diabetes and prediabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Impaired glucose tolerance, diabetes, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Coronary artery calcification in type 2 diabetes and insulin resistance: the framingham offspring study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Circadian variation of blood-pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Prediabetes is associated with abnormal circadian blood pressure variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Circadian variation of blood pressure: the basis for the chronotherapy of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals: the Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Obstructive sleep apnea as a risk factor for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Obstructive sleep apnea and incident diabetes. A historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Obstructive sleep apnea and type 2 diabetes: is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Short sleep duration is associated with reduced leptin levels and increased adiposity: Results from the Quebec family study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Contributions of hypoxia and respiratory disturbance index to sympathetic activation and blood pressure in obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Obstructive sleep apnea among obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Sleep, sleep-disordered breathing and metabolic consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Effect of continuous positive airway pressure therapy on glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Low testosterone levels are common and associated with insulin resistance in men with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Effects of acute hyperinsulinemia on testosterone serum concentrations in adult obese and normal-weight men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Hormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

The insulin resistance syndrome: definition and dietary approaches to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Metabolic syndrome and hyperglycemia: congruence and divergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Metabolic syndrome and prediabetes identify overlapping but not identical populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Changes in risk variables of metabolic syndrome since childhood in pre-diabetic and type 2 diabetic subjects: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Pre-diabetes, metabolic syndrome, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Effect of pioglitazone on metabolic syndrome risk factors: results of double-blind, multicenter, randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Adiponectin as predictor for diabetes among pre-diabetic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Islet inflammation in type 2 diabetes: from metabolic stress to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Metabolite profiles and the risk of developing diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Novel biomarkers for pre-diabetes identified by metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Non-alcoholic fatty liver disease: a diabetologist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Association between markers of fatty liver disease and impaired glucose regulation in men and women from the general population: the KORA-F4-study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Diabetes and cancer: a consensus report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

New perspective for an old antidiabetic drug: metformin as anticancer agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Are current diagnostic guidelines delaying early detection of dysglycemic states? Time for new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Inadequacies of current approaches to prediabetes and diabetes prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Autonomic dysfunction and circadian blood pressure variations in people with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12020-014-0436-2

Testosterone deficiency, cardiac health, and older men.

21 January 2018

1 reference

12 December 2020

Periodontitis is associated with aggravation of prediabetes in Zucker fatty rats

1 reference

12 December 2020

Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients

1 reference

12 December 2020

Association of type 2 diabetes with brain atrophy and cognitive impairment

1 reference

12 December 2020

Prediabetes, prehypertension ... is it time for pre-CKD?

1 reference

12 December 2020

Cognitive processes and functions in patients with type 2 diabetes in comparison to pre-diabetic patients.

1 reference

12 December 2020

Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease

1 reference

12 December 2020

Prediabetes is associated with an increased risk of testosterone deficiency, independent of obesity and metabolic syndrome

1 reference

12 December 2020

The continuing challenge of turning promising observational evidence about risk for dementia to evidence supporting prevention

1 reference

12 December 2020

Effect of hypoxia on blood glucose, hormones, and insulin receptor functions in newborn calves

1 reference

12 December 2020

Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance

1 reference

12 December 2020

Diabetes and cognitive performance: a story that is still unfolding

1 reference

12 December 2020

Markers of Sleep-Disordered Breathing and Prediabetes in US Adults.

1 reference

12 December 2020

Diabetes prevention: global health policy and perspectives from the ground

1 reference

12 December 2020

Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study

1 reference

12 December 2020

Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes

1 reference

12 December 2020

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

12 December 2020

Day and night variation in ambulatory blood pressure in type 1 diabetes mellitus with nephropathy and autonomic neuropathy

1 reference

12 December 2020

Effect of pre-diabetes on future risk of stroke: meta-analysis

1 reference

12 December 2020

Relevance of blood pressure variation in the circadian onset of cardiovascular events.

1 reference

12 December 2020

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

1 reference

12 December 2020

A comprehensive review on metabolic syndrome

1 reference

12 December 2020

How well does ambulatory blood pressure predict target-organ disease and clinical outcome in patients with hypertension?

1 reference

12 December 2020

Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary

1 reference

12 December 2020

Abnormalities in circadian blood pressure variability and endothelial function: pragmatic markers for adverse cardiometabolic profiles in asymptomatic obese adults.

1 reference

12 December 2020

Prediabetes and the risk of cancer: a meta-analysis.

1 reference

12 December 2020

Type 2 diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects: a cross-sectional study

1 reference

12 December 2020

Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up

1 reference

12 December 2020

Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.

1 reference

12 December 2020

Dysglycemia induces abnormal circadian blood pressure variability

1 reference

12 December 2020

Early vascular lesions in subjects with metabolic syndrome and prediabetes.

1 reference

12 December 2020

The effects of testosterone treatment on body composition and metabolism in middle-aged obese men

1 reference

12 December 2020

Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study.

1 reference

12 December 2020

10.1007/S12020-014-0436-2

Identifiers

DOI

1 reference

1 September 2017

1 reference